Effect of induction chemotherapy on changes of laminin and syndecan expression in oral squamous cell carcinomas: A prospective, randomized, clinicopathologic and immonuhistochemical study

Journal of Craniofacial Surgery

Volumn 16, Issue 2, 2005, Pages 205-212

  Németh, Zsolt ^a   Szigeti, Krisztián ^a   Máthé, Miklós ^a   Szabó, György ^a   Velich, Norbert ^a   Suba, Zsuzsanna ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Basement membrane; Laminin; Oral cancer; Prognostic and predictive factors; Syndecan 1

Indexed keywords

CISPLATIN; CYTOSTATIC AGENT; EPIRUBICIN; FLUOROURACIL; LAMININ; SYNDECAN; SYNDECAN 1; ANTINEOPLASTIC AGENT; MEMBRANE PROTEIN; PROTEOGLYCAN; SDC1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; ADJUVANT THERAPY; DISEASE FREE SURVIVAL; DRUG EFFECT; FOLLOW UP; FORECASTING; MIDDLE AGED; MOUTH; MOUTH TUMOR; REMISSION; TONGUE TUMOR;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MOUTH FLOOR; MOUTH NEOPLASMS; NEOADJUVANT THERAPY; PROGNOSIS; PROSPECTIVE STUDIES; PROTEOGLYCANS; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; SYNDECAN-1; SYNDECANS; TONGUE NEOPLASMS;

EID: 17844408175     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001665-200503000-00005     Document Type: Article

References (31)

1. Hermanek P, Hutter RV, Sobin LH, et al (eds). TNM Atlas Illustrated Guide to the TNM/pTNM Classification of Malignant Tumors. 4th ed. Berlin: Springer, 1997
2. Suba Z, Szabó G, Barabás J, et al. Histological evaluation of chemotherapeutically induced tumor regression. Reg Cancer Treat 1992;4:313-319
3. Tosios KI, Kapranos N, Papanicolaou SI. Loss of basement membrane components laminin and type IV collagen parallels the progression of oral epithelial neoplasia. Histopathology 1998;33:261-268
4. Inki P, Joensuu H, Grenman R, et al. Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck. Br J Cancer 1994;70:319-323
5. Friedmann Nervi C, Casale C, Starace G, et al. Significance of growth rates cell kinetics and histology in the irradiation and chemotherapy of squamous cell carcinoma of the mouth. Cancer 1973;31:10-16
6. Jacobsson PA, Eneroth CM, Killander D, et al. Histologic classification and grading of malignancy in carcinoma of the larynx (a pilot study). Acta Radiol Ther Phys Biol 1973;12:1-8
7. Micheau C, Richard JM, Marandas P, et al. La regression tumorale apres chimiotherapie locale dans les carcinomes des voies aero-digestives superieues: le point de vue pathologiste. Ann Otolaryngol 1983;100:577-580
8. Richard J, Domenge C. La chimiotherapie intra-arterielle d'induction dans les tumeurs des voies aero-digestives superieures. In: Jaquillat C, Weil M, Khayat M (eds). Neo-Adjuvant Chemotherapy. London: John Libbey Eurotext, 1986:447-453
9. Shapsay SM, Hong WK, Incze JS, et al. Histopathologic findings after cis-platinum bleomycin therapy in advanced previously untreated head and neck carcinoma. Am J Surg 1987; 136:534-538
10. Shimosato Y, Oboshi S, Baba K. Histological evaluation of effects of radiotherapy and chemotherapy for carcinomas. Jpn J Clin Oncol 1971;1:19-35
11. Sulfaro S, Frustaci S, Volpe R, et al. A pathologic assessment of tumor residue and stromal changes after intra-arterial chemotherapy for head and neck carcinomas. Cancer 1989;64:994-1001
12. Ruoslathi E, Giancotti FG. Integrins and tumor cell dissemination. Cancer Cells 1989;1:119-126
13. Albelda SM. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 1993; 68:4-17
14. Gianelli G, Milillo L, Marinosci F, et al. Altered expression of integrins and basement membrane proteins in malignant and pre-malignant lesions of oral mucosa. J Biol Regul Homeost Agents 2001;15:375-380
15. Pirila E, Sharabi A, Salo T, et al. Matrix metalloproteinases process the laminin-5 gamma2-chain and regulate epithelial cell migration. Biochem Biophys Res Commun 2003;18: 303:1012-1017
16. 2 overexpression in Head Neck squamous cell carcinoma. Int J Cancer 2002;99:583-588
17. Moriya Y, Niki T, Yamada T, et al. Increased expression of laminin-5 and its prognostic significance in lung adenocarcinomas of small size. Cancer 2001;91:1129-1141
18. Liotta LA. Tumor invasion and metastases: role of basement membrane. Am J Pathol 1984;117:339-348
19. Abrahamson DR. Recent studies on the structure and pathology of basement membranes. J Pathol 1986;149:257-278
20. Birumbaut P, Caron Y, Adnet JJ, et al. Usefulness of basement membrane markers in tumoral pathology. J Pathol 1985;145: 283-296
21. Kannan S, Balaram P, Chandran GJ, et al. Alterations in expression of basement membrane proteins during tumor progression in oral mucosa. Histopathology 1994;24:531-537
22. Sakr WA, Zarbo RJ, Jacobs JR, et al. Distribution of basement membrane in squamous cell carcinoma of the head and neck. Hum Pathol 1987;18:1043-1050
23. Harada T, Shinohara M, Nakamura S, et al. An immunohistochemical study of extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential. Virchows Arch 1994;424:257-266
24. Kumagai S, Kojima S, Imai K, et al. Inummohistologic distribution of basement membrane in oral squamous cell carcinoma. Head Neck 1994;16:51-57
25. Soukka T, Pohjola J, Inki P, et al. Reduction of syndecan-1 expression is associated with dysplastic oral epithelium. J Oral Pathol Med 2000;29:308-313
26. Inki P, Kujari H, Jalkanen M. Syndecan in carcinomas produced from transformed epithelial cells in nude mice. Lab Invest 1992;66:314-323
27. Pulkkinen JO, Penttinen M, Jalkanen M, et al. Syndecan-l: a new prognostic factor in Laryngeal Cancer. Acta Otolaryngol (Stockh) 1997;117:312-315
28. Inki P, Gomez M, Quintanilla M, et al. Expression of syndecan in transformed mouse keratinocytes. Lab Invest 1992;67:225-233
29. Anttonen A, Heikkila P, Kajanti M, et al. High syndecan-1 expression is associated with favorable outcome in squamous cell lung carcinoma treated with radical surgery. Lung Cancer 2001;32:297-305
30. Carter RL. Pathology of squamous carcinomas of the head and neck. Curr Opin Oncol 1991;3:507-511
31. Anttonen A, Kajanti M, Heikkilä P, et al. Syndecan-1 expression has prognostic significance in head and neck carcinoma. Br J Cancer 1999;79:558-564